Gene patents overturned in landmark US Supreme Court decision

Parliament house flag post

Gene patents overturned in landmark US Supreme Court decision

Posted 17/06/2013 by Genevieve Butler



The landmark decision of the US Supreme Court in the Association for Molecular Pathology v Myriad Genetics case would appear to have overturned three decades of gene patent awards, signaling a clear shift from the Patent and Trademark Office’s past practice.

Nearly 20 years ago, Myriad obtained several pa­tents after discovering the precise location and sequence of the BRCA1 and BRCA2 genes, mutations of which can dramatically in­crease the risk of breast and ovarian cancer. This knowledge enabled Myriad to develop medical tests for detecting muta­tions in these genes to assess a patient’s cancer risk.

The validity of the patents was challenged by a consortium of interested parties. Cancer patients and medical associations were anxious to reduce the cost of such genetic testing, which can run as high as $US 4,000. Scientists raised concerns over restrictions on their ability to use the genes for research, and the impact this had on the free flow of scientific information.

On 13 June 2013, the Supreme Court held that a naturally occurring DNA segment is a product of nature and not patent-eligible merely because it has been isolated. However, synthetic genetic material known as complementary DNA (cDNA) can be patented because it is not naturally occurring. This means that Myriad no longer has the exclusive right to isolate an individual’s BRCA1 and BRCA2 genes, but it can claim exclusive rights to synthetically create BRCA cDNA.

Until the ruling, Myriad held a monopoly on testing for BRCA genes - an issue which was recently brought to the public’s attention with actress Angelina Jolie’s announcement that she had a double mastectomy after testing positive for one of the genes.

The US Patent Act (section 101) permits patents to be issued to in­venters or discoverers of any new and useful composition of matter, but the court held that ‘laws of nature, natural phenomena, and abstract ideas are basic tools of scientific and technological work that lie beyond the domain of patent protection’.

The court explained that without this exception, there would be a danger that the grant of patents would tie up the use of such tools and inhibit future innovation premised upon them. ‘This would be at odds with the very point of patents, which exist to promote creation,’ Thomas J concluded.

Delivering a unanimous judgment for the Supreme Court, Thomas J emphasised that ‘patent protection strikes a delicate balance between creating incen­tives that lead to creation, invention, and discovery, and impeding the flow of information that might permit, indeed spur, invention.’ This standard was used to determine whether Myriad’s pa­tents claim a new and useful composition of matter or claim naturally occurring phenomena.

Myriad’s DNA claim was found to fall within the law of nature exception. While Myriad found an im­portant and useful gene, ‘ground breaking, innovative, or even brilliant discovery’ and extensive effort was not enough to satisfy the ‘new and useful composition of matter’ requirement.

‘Myriad did not create anything’ with isolated DNA, according to Thomas J, as separating the gene from its surrounding genetic material was not an act of invention. However, the cDNA at issue is not a ‘product of nature’, as the lab technician created something new and complementary to the BRCA gene, making it is patent-eligible.

While seen as something of a compromise, this ruling could have profound implications for the biotechnology and drug industry. Myriad’s patents were due to expire over the coming years due to the 20-year limit on patents, but the decision has implications far beyond the scope of the BRCA1 and BRCA2 patents.

Concerns have been raised that it could discourage investment in genetic research by taking away commercial incentive to continue researching into DNA. Some biotech research companies saw it as an about-turn in the international approach to intellectual property rights surrounding genetics.

The US Supreme Court decision forces a change at the US Patent and Trademark Office, which has been awarding gene patents since 1982.

It also contradicts a ruling on gene patenting in Australia's Federal Court in February this year, which decided in favour of Myriad after a similar lawsuit was brought by Cancer Voices Australia. The Federal Court ruled that the two genes, extracted from natural cells obtained from the human body and 'purged of other biological materials,' constituted a 'manner of manufacture' and could therefore be patented’. That decision has been appealed to the Full Court of the Federal Court, with a hearing expected in August.

The Australian Federal Court is not legally bound to follow the US Supreme Court decision, but will no doubt closely examine the US Supreme Court decision in its deliberations.

Comments

  • 21/01/2014 1:53 PM
    Flabmeister said:

    AS well as a monopoly, do Myriad have a patent for the testing process?

  • 21/01/2014 1:53 PM
    Genevieve Butler said:

    Myriad held patents on the tests from the late 1990s until the Supreme Court decision in Association for Molecular Pathology v Myriad Genetics. The ruling invalidated five patents held by Myriad, which underpinned Myriad’s BRACAnalysis test, thus breaking Myriad's monopoly on BRCA testing. One of the effects of the case was to open the market for testing to competition. Several other companies immediately said they would offer such tests at a lower cost.


Thank you for your comment. If it does not require moderation, it will appear shortly.

Add your comment

[Click to expand]




Facebook LinkedIn Twitter Add | Email Print

FlagPost

Flagpost is a blog on current issues of interest to members of the Australian Parliament


Parliamentary Library Logo showing Information Analysis & Advice

Archive

Syndication

Tagcloud

refugees asylum immigration Australian foreign policy Parliament climate change elections women social security Australian Bureau of Statistics Employment indigenous Australians Sport illicit drugs gambling people trafficking taxation Medicare welfare reform Australian Defence Force higher education welfare policy United Nations health financing Asia Middle East criminal law disability Australian Sports Anti-Doping Agency World Anti-Doping Agency United States federal budget school education forced labour statistics Australian Electoral Commission WADA income management Industrial Relations emissions trading dental health Australia in the Asian Century steroids detention 43rd Parliament Private health insurance OECD ASADA labour force transport Law Enforcement Australian Federal Police aid people smuggling poker machines National Disability Insurance Scheme Australian Crime Commission slavery Australian Public Service constitution International Women's Day corruption Afghanistan Fair Work Act child protection Aviation debt federal election 2013 parliamentary procedure ALP New Zealand Newstart Parenting Payment Census politics High Court skilled migration election results voting mental health Federal Court terrorist groups Higher Education Loan Program HECS governance Papua New Guinea youth paid parental leave environment foreign debt gross debt net debt defence capability customs Senate doping health crime health risks multiculturalism aged care Gonski Review of Funding for Schooling sex slavery sea farers Special Rapporteur Electoral reform political parties banking firearms public policy Population violence against women domestic violence China ADRV terrorism science research and development social media pensions welfare ASIO intelligence community Australian Security Intelligence Organisation accountability public service reform Carbon Pricing Mechanism carbon tax mining military history employer employee fishing by-election European Union same sex relationships international relations coal seam gas family assistance planning Senators and Members United Nations Security Council Australian economy food vocational education and training Drugs health reform Indonesia children codes of conduct terrorist financing pharmaceutical benefits scheme Parliamentary remuneration health system money laundering early childhood education Canada Financial sector UK Parliament national security fuel disability employment Tasmania integrity transparency Australian Secret Intelligence Service sexual abuse federal state relations World Trade Organization Australia housing affordability bulk billing water renewable energy children's health health policy Governor-General US economy export liquefied natural gas foreign bribery question time speaker superannuation expertise climate Intergovernmental Panel on Climate Change leadership Department of Agriculture Fisheries and Forestry food labelling Pacific Islands reserved seats new psychoactive substances synthetic drugs UNODC carbon markets Indigenous constitutional recognition of local government local government consumer laws PISA royal commission US politics language education baby bonus Leaders of the Opposition Australia Greens federal election 2010 servitude Trafficking Protocol energy forced marriage rural and regional Northern Territory Emergency Response ministries Hung Parliament social citizenship human rights child care funding refugees immigration asylum procurement Indigenous health e-voting internet voting nsw state elections 44th Parliament 2015 ABS Age Pension Death penalty capital punishment execution Bali nine Bali bombings Trade EU China soft power education Fiji India Disability Support Pension Antarctica Diplomacy by-elections state and territories workers Bills anti-corruption fraud bribery corporate ownership whistleblower G20 economic reform innovation standards NATO Members of Parliament Scottish referendum Middle East; national security; terrorism social services Criminal Code Amendment (Misrepresentation of Age to a Minor) Bill 2013 online grooming sexual assault of minors ACT Assembly public health smoking plain packaging tobacco cigarettes Asia; Japan; international relations Work Health and Safety Migration; asylum seekers; regional processing China; United States; international relations fiscal policy Racial Discrimination Act; social policy; human rights; indigenous Australians Foreign policy Southeast Asia Israel Palestine regional unemployment asylum refugees immigration political finance donations foreign aid Economics efficiency productivity human rights; Racial Discrimination Act employment law bullying asylum seekers Animal law; food copyright Australian Law Reform Commission industry peace keeping contracts workplace policies trade unions same-sex marriage disorderly conduct retirement Parliament House standing orders public housing prime ministers election timetable sitting days First speech defence budget submarines Somalia United Kingdom GDP forestry world heritage political engagement leave loading Trade; tariffs; safeguards; Anti-dumping public interest disclosure whistleblowing Productivity Commission regulation limitation period universities Ireland cancer gene patents genetic testing suspension of standing and sessional orders animal health live exports welfare systems infant mortality middle class welfare honorary citizen railways disciplinary tribunals standard of proof World Health Organisation arts international students skilled graduate visas temporary employment visas apologies roads Italy national heritage NHMRC nutrition anti-dumping Constitutional reform referendum Rent Assistance competition policy obesity evidence law sacrament of confession US presidential election international days DFAT UN General Assembly deregulation Regulation Impact Statements administrative law small business Breaker Morant homelessness regional engagement social determinants of health abortion Youth Allowance Members suspension citizen engagement policymaking workplace health and safety Trafficking in Persons Report marine reserves hearing TAFE Victoria astronomy resources sector YMCA youth parliament alcohol Korea rebate Australian Greens presidential nomination Racial Discrimination Act entitlements political parties preselection solar hot water Financial Action Taskforce Horn of Africa peacekeeping piracy Great Barrier Reef Stronger futures political financing political education social inclusion Social Inclusion Board maritime early childhood National Quality Framework for Early Childhood Education and Care Murray-Darling Basin Iran sanctions Norway hospitals republic President Barack Obama Presidential visits ANZUS qantas counselling Korean peninsula

Show all
Show less
Back to top